NEW YORK (GenomeWeb News) – SQI Diagnostics has raised C$2.3 million (US$2.3 million) in gross proceeds in a second tranche of a non-brokered private placement.

The tranche is part of a placement intended to bring in as much as C$9 million that the Canadian microarray-based diagnostics firm announced a week ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.